Trial Profile
Multicenter, randomized, double-blind, placebo-controlled study of the efficacy and tolerability of indiplon therapy initiated with sertraline versus sertraline monotherapy in subjects with insomnia and co-existing major depressive disorder
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Indiplon (Primary) ; Sertraline
- Indications Insomnia; Major depressive disorder
- Focus Registrational; Therapeutic Use
- Sponsors Neurocrine Biosciences
- 05 Jan 2007 Status change
- 27 Nov 2005 New trial record.